Charles A. Reinhart III, CPA, M.B.A.
Net Worth
Last updated:
What is Charles A. Reinhart III, CPA, M.B.A. net worth?
The estimated net worth of Mr. Charles A. Reinhart III, CPA, M.B.A. is at least $6,179,708 as of 7 Jun 2023. He owns shares worth $847,039 as insider, has earned $416,149 from insider trading and has received compensation worth at least $4,916,520 in Pacira BioSciences, Inc..
What is the salary of Charles A. Reinhart III, CPA, M.B.A.?
Mr. Charles A. Reinhart III, CPA, M.B.A. salary is $702,360 per year as Chief Financial Officer in Pacira BioSciences, Inc..
How old is Charles A. Reinhart III, CPA, M.B.A.?
Mr. Charles A. Reinhart III, CPA, M.B.A. is 64 years old, born in 1961.
What stocks does Charles A. Reinhart III, CPA, M.B.A. currently own?
As insider, Mr. Charles A. Reinhart III, CPA, M.B.A. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 33,626 | $25.19 | $847,039 |
What does Pacira BioSciences, Inc. do?
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Charles A. Reinhart III, CPA, M.B.A. insider trading
Pacira BioSciences, Inc.
Mr. Charles A. Reinhart III, CPA, M.B.A. has made 7 insider trades between 2018-2023, according to the Form 4 filled with the SEC. Most recently he sold 1,371 units of PCRX stock worth $51,913 on 7 Jun 2023.
The largest trade he's ever made was exercising 2,648 units of PCRX stock on 4 Jun 2021. As of 7 Jun 2023 he still owns at least 33,626 units of PCRX stock.
Pacira BioSciences key executives
Pacira BioSciences, Inc. executives and other stock owners filed with the SEC:
- Mr. Charles A. Reinhart III, CPA, M.B.A. (64) Chief Financial Officer
- Mr. David M. Stack (75) Chairman & Chief Executive Officer
- Mr. Max Reinhardt (54) Pres of Rest of World
- Ms. Kristen Williams (51) Chief Admin. Officer & Sec.